Endurant Capital Management’s Charles River Laboratories CRL Stock Holding History

Endurant Capital Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-6,258	Closed	-$1.36M	–	58
2022 Q4	$1.36M	Buy	+6,258	New	+$1.37M	0.55%	33
2022 Q2	–	Sell	-3,308	Closed	-$939K	–	58
2022 Q1	$939K	Sell	3,308 -15,278	-82%	-$4.71M	0.25%	58
2021 Q4	$7M	Buy	+18,586	New	+$7.22M	1.69%	19
2020 Q2	–	Sell	-13,147	Closed	-$1.66M	–	63
2020 Q1	$1.66M	Buy	+13,147	New	+$1.97M	0.75%	31
2019 Q4	–	Sell	-74,986	Closed	-$9.93M	–	59
2019 Q3	$9.93M	Buy	+74,986	New	+$10.1M	3.56%	12
2017 Q3	–	Sell	-28,248	Closed	-$2.86M	–	90
2017 Q2	$2.86M	Buy	28,248 +4,460	+19%	+$411K	0.81%	36
2017 Q1	$2.14M	Buy	23,788 +5,300	+29%	+$450K	0.69%	42
2016 Q4	$1.41M	Sell	18,488 -17,300	-48%	-$1.31M	0.58%	46
2016 Q3	$2.98M	Sell	35,788 -4,300	-11%	-$360K	1.11%	32
2016 Q2	$3.31M	Buy	40,088 +29,200	+268%	+$2.41M	1.1%	29
2016 Q1	$827K	Buy	10,888 +2,300	+27%	+$170K	0.27%	60
2015 Q4	$690K	Buy	8,588 +2,088	+32%	+$151K	0.23%	62
2015 Q3	$413K	Buy	+6,500	New	+$467K	0.14%	68

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Endurant Capital Management's CRL Position: Q1 2023 in Review

Endurant Capital Management sold out of Charles River Laboratories (CRL) in Q1 2023, closing a stake of 6,258 shares — an estimated $1.36M sold.

Endurant Capital Management first reported a position in CRL in Q3 2015 and held it in 13 quarters. The position peaked at $9.93M in Q3 2019. 621 funds tracked by Wall St. Rank hold CRL as of Q1 2023.

Endurant Capital Management reported no remaining Charles River Laboratories position as of Q1 2023 after selling out during the quarter.
Endurant Capital Management sold 6,258 Charles River Laboratories shares in Q1 2023, an estimated $1.36M.
Endurant Capital Management first reported a position in Charles River Laboratories in Q3 2015 and held it in 13 quarters.
Endurant Capital Management's Charles River Laboratories position peaked at $9.93M in Q3 2019.
621 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2023.

Based on Endurant Capital Management's 13F filing for Q1 2023, filed 15 May 2023.